Enavate Sciences Gp, Llc Portfolio Stock Holdings
Enavate Sciences Gp, Llc disclosed 7 stock positions valued at approximately $351.5 million in its latest SEC 13F filing. The largest holdings include SIONNA THERAPEUTICS INC, IMMUNOME INC, and COMPASS THERAPEUTICS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 7
- Portfolio Value
- $351.5M
Holdings by Sector
Enavate Sciences Gp, Llc Portfolio Holdings in Q1 2026
3 holdings in the latest reporting period.
Page 1 of 1